Clocapramine

This classification denotes an antidepressant agent with the molecular formula C28H37ClN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6EEL1GB72K, chemically known as 3-chloro-5-(3-(4-piperidino-4- carbamoylpiperidino)propyl)-10,11-dihydro-5h- dibenz(b,f)azepine dihydrochloride monohydrate but generally known as clocapramine, which bears US NIH Compound Identifier 2793. European Medicines Agency schedules Clocapramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06683MIG. The term CLOCAPRAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). CLOCAPRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clocapramine under HS 29333999 and SITC 51574. As of Q4 2014, CLOCAPRAMINE remains the US FDA Preferred Term for this commodity. Clocapramine bears US NLM identifiers UMLS ID C0047305 and NCI Concept Code C78010. SMILES: CLC1CC2N(CCCN3CCC(N4CCCCC4)(CC3)C(=O)N)C3C(CCC2CC1)CCCC3.